Chemotherapy News and Research

Latest Chemotherapy News and Research

FDA approves new combo treatment for patients with advanced sarcomas

FDA approves new combo treatment for patients with advanced sarcomas

Gut microbiome may help improve immunotherapy response in melanoma patients

Gut microbiome may help improve immunotherapy response in melanoma patients

Combination of immunotherapy options improves survival of patients with deadly forms of skin cancer

Combination of immunotherapy options improves survival of patients with deadly forms of skin cancer

GW scientist awarded $2.8 million NIH grant to continue research on corneal wound healing

GW scientist awarded $2.8 million NIH grant to continue research on corneal wound healing

Scientists discover novel therapeutic target and treatment strategy for acute myeloid leukemia

Scientists discover novel therapeutic target and treatment strategy for acute myeloid leukemia

Researchers find certain short junk DNA play key role in development of Ewing sarcoma

Researchers find certain short junk DNA play key role in development of Ewing sarcoma

Study shows promise for successful ovarian transplantation in future

Study shows promise for successful ovarian transplantation in future

Genetic susceptibility could help identify breast cancer patients at risk of developing VTE

Genetic susceptibility could help identify breast cancer patients at risk of developing VTE

UGA researchers find new way to improve cancer-killing power of chemotherapy

UGA researchers find new way to improve cancer-killing power of chemotherapy

High out-of-pocket costs, rather than race/ethnicity, may impact adjuvant endocrine therapy adherence

High out-of-pocket costs, rather than race/ethnicity, may impact adjuvant endocrine therapy adherence

Researchers identify potential new treatment for brain cancer by targeting genes linked to microcephaly

Researchers identify potential new treatment for brain cancer by targeting genes linked to microcephaly

Study shows only 44% of patients receive accepted, best treatment for cervical cancer

Study shows only 44% of patients receive accepted, best treatment for cervical cancer

Combination treatment can reduce tumor's resistance to chemotherapy in ovarian cancer

Combination treatment can reduce tumor's resistance to chemotherapy in ovarian cancer

NUS researchers identify molecular switch that makes breast cancer cells more aggressive

NUS researchers identify molecular switch that makes breast cancer cells more aggressive

Researchers identify protein linked to negative effects of senescence

Researchers identify protein linked to negative effects of senescence

Penn study reveals new sights into how some intestinal cells can withstand chemotherapy and radiation

Penn study reveals new sights into how some intestinal cells can withstand chemotherapy and radiation

Simple web-based program may help alleviate mild cognitive problems in cancer survivors

Simple web-based program may help alleviate mild cognitive problems in cancer survivors

Standardize 4 Safety initiative finalizes list of recommendations for adult IV continuous infusions

Standardize 4 Safety initiative finalizes list of recommendations for adult IV continuous infusions

Study estimates prevalence of self-reported immunosuppressed adults in the U.S.

Study estimates prevalence of self-reported immunosuppressed adults in the U.S.

Research findings may lead to new treatment option for ovarian cancer

Research findings may lead to new treatment option for ovarian cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.